A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/18 (2006.01) C07K 14/475 (2006.01)
Patent
CA 2625395
Modified VEGF proteins that inhibit VEGF-mediated activation or proliferation of endothelial cells are disclosed. The analogs may be used to inhibit VEGF- mediated activation of endothelial cells in angiogenesis-associated diseases such as cancer, inflammatory diseases, eye diseases, and skin disorders.
L'invention concerne des protéines VEGF modifiées qui inhibent l'activation ou la prolifération induite par VEGF des cellules endothéliales. Ces analogues peuvent être utilisés pour inhiber l'activation induite par VEGF des cellules endothéliales dans le cas de maladies associées à l'angiogenèse, telles que le cancer, les maladies inflammatoires, les maladies oculaires et les troubles cutanés.
Szkudlinski Mariusz W.
Weintraub Bruce D.
Deeth Williams Wall Llp
Trophogen Inc.
LandOfFree
Vegf analogs and methods of use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Vegf analogs and methods of use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vegf analogs and methods of use will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1594639